Effects of fenoldopam infusion in complex cardiac surgical operations: A prospective, randomized, double-blind, placebo-controlled study

Minerva Anestesiologica

Volumn 76, Issue 4, 2010, Pages 249-259

  Ranucci, M ^a   de Benedetti, D ^a   Bianchini, C ^a   Castelvecchio, S ^a   Ballotta, A ^a   Frigiola, A ^a   Menicanti, L ^a  

^a IRCCS   (Italy)

Author keywords

Cardiac surgical procedures; Cardiopulmonary bypass; Vasodilatation

Indexed keywords

ATROPINE; CISATRACURIUM; FENOLDOPAM MESILATE; FENTANYL; FUROSEMIDE; LACTIC ACID; MIDAZOLAM; NITROPRUSSIDE SODIUM; NORADRENALIN; OXYGEN; PLACEBO; PROMETHAZINE; REMIFENTANIL;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART OUTPUT; HEART SURGERY; HUMAN; KIDNEY FUNCTION; KIDNEY PERFUSION; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OXYGEN TRANSPORT; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; TREATMENT DURATION; TREATMENT OUTCOME; URINE VOLUME;

AGED; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; FEMALE; FENOLDOPAM; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 77950443592     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resources utilization. Ann Intern Med 1998;128:194-203.
2. Provenchere S, Plantefeve G, Hufnagel G, Vicaut E, De aumas C, Lecharny JB et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: incidence, risk factors, and effect on clinical outcome. Anesth Analg 2003;96:1258-64.
3. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F et al. Preoperative renal risk stratification. Circulation 1997;95:878-84.
4. Llopart T, Lombardi R, Forselledo M, Andrade R. Acute renal failure in open heart surgery. Ren Fail 1997;19:319-23.
5. Wijeysundera DN, Karkouti K, Dupuis J-Y, Callum JL, Cheng D, Dupuis JY et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007;297;1801-9.
6. Fischer UM, Weissenberger WK, Warters RD, Geissler HJ, Allen SJ, Mehlhorn U. Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 2002;7:401-6.
7. Ranucci M, Romitti F, Isgrò G, Cotza M, Brozzi S, Boncilli S et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg 2005;80:2213-20.
8. Fang WC, Helm RE, Krieger KH, Rosengart TK, DuBois WJ, Sason C et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997;96(Suppl II):194-9.
9. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg 2003;125:1438-50.
10. Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003;76:784-92.
11. Poinsot G, Romand J-A, Favre H, Suter PM. Fenoldopam improves renal hemodynamics impaired by positive end-expiratory pressure. Anesthesiology 1993;79:680-4.
12. Shusterman NH, Elliot WJ, White WB. Fenoldopam but not nitroprusside improves renal function in severely hypertensive patients with impaired renal function. Am J Med 1993;95:161-8.
13. Garwood S, Swamidoss CP, Davis EA, Samson L, Hines RL. A case-series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction. J Cardiothorac Vasc Anesth 2003;17:17-21.
14. Caimmi PP, Pagani L, Micalizzi E, Fiume C, Guani S, Bernardi M et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003;17:491-4.
15. Ranucci M, Soro G, Barzaghi N, Locatelli A, Giordano, Vavassori A et al. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 2004;78:1332-7.
16. Bove T, Landoni G, Calabrò MG, Aletti G, Marino G, Cerchierini E et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005;111:3230-5.
17. Barr LF, Kolodner K. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Crit Care Med 2008;36:1427-35.
18. Landoni G, Biondi-Zoccai GG, Marino G, Bove T, Fochi O, Maj G et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2008;22:27-33.
19. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94.
20. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, the ADQI workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R12.
21. Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005;16:162-8.
22. Ranucci M, De Toffol B, Isgrò G, Romitti F, Conti D, Vicentini M. Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care 2006;10:R167.
23. Ranucci M, Pavesi M, Mazza E, Bertucci C, Frigiola A, Menicanti L et al. Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass technique. Perfusion 1994;9:319-26.
24. Zanardo G, Michielon P, Paccagnella A, Rosi P, Calò M, Salandin V et al. Acute renal failure in the patients undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 1994;107:1489-95.
25. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343-8.
26. White WB, Halley SE. Comparative effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension. Arch Intern Med 1989;149:870-4.
27. Elliott WJ, Weber RR, Nelson KS, Oliner CM, Fumo MT, Gretler DD et al. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation 1990;81:970-7.
28. Cogliati AA, Vellutini R, Nardini A, Urovi S, Hamdan M, Landoni G et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth 2007;21:847-50.
29. Roasio A, Lobreglio R, Santin A, Landoni G, Verdecchia C. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. J Cardiothorac Vasc Anesth 2008;22:23-6.
30. Landoni G, Bove T, Crivellari M, Poli D, Fochi O, Marchetti C et al. Acute renal failure after isolated CABG surgery: six years of experience. Minerva Anestesiol 2007;73:559-65.
31. Karajala V, Mansour W, Kellum JA. Diuretics in acute kidney injury. Minerva Anestesiol 2009;75:251-7.